Investors Research Corp’s Axcelis ACLS Stock Holding History

Investors Research Corp’s Portfolio ACLS Stock Details ACLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-1,000	Closed	-$28K	–	1084
2020 Q2	$28K	Hold	1,000	–	–	0.01%	596
2020 Q1	$18K	Hold	1,000	–	–	0.01%	633
2019 Q4	$24K	Hold	1,000	–	–	0.01%	661
2019 Q3	$17K	Hold	1,000	–	–	0.01%	735
2019 Q2	$15K	Hold	1,000	–	–	0.01%	745
2019 Q1	$20K	Buy	+1,000	New	+$20.3K	0.01%	676

Other funds holding ACLS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Senvest Management New York $3.41B AUM 66.27% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Investors Research Corp's ACLS Position: Q3 2020 in Review

Investors Research Corp sold out of Axcelis (ACLS) in Q3 2020, closing a stake of 1,000 shares — an estimated $28K sold.

Investors Research Corp first reported a position in ACLS in Q1 2019 and held it in 6 quarters. The position peaked at $28K in Q2 2020. 177 funds tracked by Wall St. Rank hold ACLS as of Q3 2020.

Investors Research Corp reported no remaining Axcelis position as of Q3 2020 after selling out during the quarter.
Investors Research Corp sold 1,000 Axcelis shares in Q3 2020, an estimated $28K.
Investors Research Corp first reported a position in Axcelis in Q1 2019 and held it in 6 quarters.
Investors Research Corp's Axcelis position peaked at $28K in Q2 2020.
177 funds tracked by Wall St. Rank held Axcelis as of Q3 2020.

Based on Investors Research Corp's 13F filing for Q3 2020, filed 20 Oct 2020.